Relationship between endothelial nitric oxide synthase, insulin resistance and macrovascular disease in patients with acute myocardial infarction

Journal of International Medical Research

Volumn 40, Issue 2, 2012, Pages 687-693

  Li, J L ^a,b   Yang, Z ^a,b   Wu, S ^a   Kong, J ^a  

^a JILIN UNIVERSITY   (China)

^b HEILONGJIANG PROVINCIAL HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Endothelial nitric oxide synthase; Insulin resistance; Macrovascular disease; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GLUCOSE; INSULIN; NITRIC OXIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; VASCULAR DISEASE;

EID: 84860481754     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000232     Document Type: Article

References (23)

1. Frattaroli J, Weidner G, Merritt-Worden TA, et al: Angina pectoris and atherosclerotic risk factors in the multisite cardiac lifestyle intervention program. Am J Cardiol 2008; 101: 911-918.
2. Sato A, Ohigashi H, Nozato T, et al: Coronary artery spatial distribution, morphology, and composition of nonculprit coronary plaques by 64-slice computed tomographic angiography in patients with acute myocardial infarction. Am J Cardiol 2010; 105: 930-935.
3. Kruk M, Przyluski J, Kalinczuk L, et al: Cumulative incidence of coronary lesions with vulnerable characteristics in patients with stable angina pectoris: An intravascular ultrasound and angiographic study. Int J Cardiol 2005; 102: 201-206.
4. Sánchez FA, Rana R, González FG, et al: Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS) regulation of hyperpermeability. J Biol Chem 2011; 286: 30409-30414.
5. Miyazaki M, Sakonjo H, Takai S: Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet. Br J Pharmacol 1999; 128: 523-529.
6. Dashwood MR, Tsui JC: Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade. Atherosclerosis 2002; 160: 297-304.
7. Haenni A, Lind L, Reneland R, et al: Blood pressure changes in relation to sodium and calcium status in induced hyperinsulinemia. Blood Press 2000; 9: 116-120.
8. Steinberger J, Daniels SR: Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 2003; 107: 1448-1453.
9. Li X, Zhang N, Li Y, et al: Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: A double-blind, randomized, controlled study. J Int Med Res 2011; 39: 358-365.
10. Saely CH, Aczel S, Marte T, et al: The metabolic syndrome, insulin resistance, and cardio vascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab 2005; 90: 5698-5703.
11. Nigro J, Osman N, Dart AM, et al: Insulin resistance and atherosclerosis. Endocrine Rev 2006; 27: 242-259.
12. Harris MB, Ju H, Venema VJ, et al: Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 2001; 276: 16587-16591.
13. Thygesen K, Alpert JS, White HD: Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50: 2173-2195.
14. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Bloomgarden ZT: American Diabetes Association Annual Meeting, 1999: insulin action and the development of type 2 diabetes. Diabetes Care 2000; 23: 248-252.
16. Lee JM, Kim SR, Yoo SJ, et al: The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res 2009; 37: 1803-1812.
17. Savage DB, Petersen KF, Shulman GI: Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 2005; 45: 828-833.
18. Meigs JB, Wilson PW, Nathan DM, et al: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160-2167.
19. Farouque HM, Meredith IT: The assessment of endothelial function in humans. Coron Artery Dis 2001; 12: 445-454.
20. Törnblom SA, Maul H, Klimaviciute A, et al: mRNA expression and localization of bNOS, eNOS and iNOS in human cervix at preterm and term labour. Reprod Biol Endocrinol 2005; 3: 33.
21. McConell GK, Bradley SJ, Stephens TJ, et al: Skeletal muscle nNOSμ protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 2007; 293: R821-R828.
22. Xu G, Li Y, Yang J, et al: Effect of recombinant Mce4A protein of Mycobacterium bovis on expression of TNF-α, iNOS, IL-6, and IL-12 in bovine alveolar macrophages. Mol Cell Biochem 2007; 302: 1-7.
23. Rämet ME, Rämet M, Lu Q, et al: High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J Am Coll Cardiol 2003; 41: 2288-2297.